NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
SWTX SpringWorks Therapeutics
- 53.975
- -0.165-0.30%
Trading Feb 27 10:42 ET
4.04BMarket Cap-15.51P/E (TTM)
54.810High53.170Low243.50KVolume54.350Open54.140Pre Close13.18MTurnover0.33%Turnover RatioLossP/E (Static)74.94MShares62.00052wk High8.41P/B3.98BFloat Cap28.21052wk Low--Dividend TTM73.69MShs Float96.480Historical High--Div YieldTTM3.03%Amplitude13.600Historical Low54.129Avg Price1Lot Size
SpringWorks Therapeutics News
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Saqib
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ashar Bhavesh
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LYNCH DANIEL
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SpringWorks Therapeutics | 10-K: FY2024 Annual Report
SpringWorks Therapeutics | 8-K: SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Saqib
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LYNCH DANIEL
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Saqib
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | SCHEDULE 13G/A: Others
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pichl Daniel
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LYNCH DANIEL
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Saqib
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hambleton Julie
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Edris Badreddin
SpringWorks Therapeutics | 8-K: Current report
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144